Atrial fibrillation and comorbidities: Clinical characteristics and antithrombotic treatment in GLORIA-AF.
Monika KoziełChristine TeutschJonathan L HalperinKenneth J RothmanHans-Christoph DienerChang-Sheng MaSabrina MarlerShihai LuVenkatesh K GurusamyMenno V HuismanGregory Y H Lipnull nullPublished in: PloS one (2021)
Multimorbid AF patients prescribed NOACs have fewer comorbidities than those prescribed VKAs. Age, AF pattern, comorbidities, and renal function are associated with OAC prescription.